You have 9 free searches left this month | for more free features.

Secured drug intake

Showing 1 - 25 of >10,000

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Metastatic Renal Cell Carcinoma Trial in France (PRISM care program)

Recruiting
  • Metastatic Renal Cell Carcinoma
  • PRISM care program
  • Angers, France
  • +11 more
Apr 22, 2022

Substance-Related Disorders, Treatment Adherence Trial in Albuquerque (Motivational Interviewing at Intake (MII), Intake as

Recruiting
  • Substance-Related Disorders
  • Treatment Adherence
  • Motivational Interviewing at Intake (MII)
  • Intake as Usual (IAU)
  • Albuquerque, New Mexico
    Turning Point Recovery Center
Aug 2, 2022

Hematologic Cancers, Solid Tumors, Metastatic Cancer Trial in Villejuif (Crizotinib)

Active, not recruiting
  • Hematologic Cancers
  • +2 more
  • Villejuif, Ile De France, France
    Gustave Roussy
Sep 5, 2022

Osteoarthritis, Knee, Osteoarthritis, Hip, Chronic Pain Trial in Clermont-Ferrand (therapeutic program including intermittent

Not yet recruiting
  • Osteoarthritis, Knee
  • +2 more
  • therapeutic program including intermittent drug intake and multimodal rehabilitation program
  • Clermont-Ferrand, France
    CHU Clemront-Ferrand
Mar 9, 2023

Marijuana Use, Opioid Use Trial (Marijuana, Opioid)

Not yet recruiting
  • Marijuana Use
  • Opioid Use
  • (no location specified)
Aug 2, 2022

Energy Intake, Food Intake, E-Cig Use Trial in Richmond (Vaping condition, Control condition)

Recruiting
  • Energy Intake
  • +3 more
  • Vaping condition
  • Control condition
  • Richmond, Virginia
    Center for the Study of Tobacco Products
Feb 10, 2022

HIV-1-infection, Hepatic Impairment Trial in Smolensk (Elpida®, Dolutegravir, Sofosbuvir)

Completed
  • HIV-1-infection
  • Hepatic Impairment
  • Smolensk, Russian Federation
    Regional State Budgetary Healthcare Institution "Smolensk Region
Jan 10, 2022

Hypertension, Drug Therapy, Primary Health Care Trial in Gothenburg, Skövde (Time of ordinary antihypertensive medication

Not yet recruiting
  • Hypertension
  • +2 more
  • Time of ordinary antihypertensive medication intake
  • Gothenburg, Sweden
  • +2 more
Apr 4, 2022

Nalmefene Hydrochloride Hydrate in Alcohol Dependence

Active, not recruiting
  • Alcohol Dependence
  • Nalmefene Hydrochloride Hydrate
  • Osaka, Japan
    Otsuka Pharmaceutical Co., Ltd.
Apr 6, 2022

Healthy Participants Trial in Minato-ku (E7090, Rabeprazole 20 mg, Rifampin 600 mg)

Completed
  • Healthy Participants
  • Minato-ku, Tokoyo, Japan
    Eisai trial site #1
Oct 29, 2021

Hypertension Trial in Clermont-Ferrand (Phenotyping, Drug intake)

Not yet recruiting
  • Hypertension
  • Phenotyping
  • Drug intake
  • Clermont-Ferrand, Auvergne, France
    Platform of Clinical Investigation / Clinical Investigation Cent
Nov 2, 2021

Hypertension Trial in Beijing (SPH3127 200mg Panel A, SPH3127 200mg Panel B)

Completed
  • Hypertension
  • SPH3127 200mg Panel A
  • SPH3127 200mg Panel B
  • Beijing, Beijing, China
    The capital medical university affiliated Beijing anzhen hospita
Nov 11, 2021

Medication Adherence, HIV Trial in Pittsburgh (dolutegravir oral tablet 50mg, emtricitabine/tenofovir alafenamide oral tablet

Completed
  • Medication Adherence
  • HIV
  • dolutegravir oral tablet 50mg
  • +3 more
  • Pittsburgh, Pennsylvania
    HIV/AIDS Clinical Research Unit / University of Pittsburgh
Mar 2, 2022

Prostate Cancer Trial in Nijmegen (abiraterone)

Completed
  • Prostate Cancer
  • Nijmegen, Netherlands
    Radboud UMC
Dec 4, 2020

Diabetic Neuropathies Trial in Russian Federation (Cytoflavin (Inosine + Nicotinamide + Riboflavin + Succinic Acid), Placebo)

Completed
  • Diabetic Neuropathies
  • Cytoflavin (Inosine + Nicotinamide + Riboflavin + Succinic Acid)
  • Placebo
  • Moscow, Russian Federation
  • +15 more
Jan 25, 2023

Orthostatic Hypotension, Falls Trial in Portland (Medication review, Nutrition/Salt intake, Education)

Completed
  • Orthostatic Hypotension
  • Falls
  • Medication review
  • +4 more
  • Portland, Oregon
    VA Portland Health Care System, Portland, OR
Jun 10, 2021

Gut Microbiome, Mood Disorders Trial in Beirut (Cerebiome, Placebo)

Not yet recruiting
  • Gut Microbiome
  • Mood Disorders
  • Beirut, Lebanon
    Saint-Joseph University
Dec 2, 2022

Obesity Trial in Verona (Placebo, Libramed)

Recruiting
  • Obesity
  • Verona, Italy
    Pediatric Diabetes and Metabolic Disorders Unit, Department of L
Jan 12, 2021

Tuberculosis Trial in Lambaréné (VOT with and without cash incentive)

Completed
  • Tuberculosis
  • VOT with and without cash incentive
  • Lambaréné, Gabon
    Centre de recherches médicales de Lambaréné
May 9, 2023

Marijuana Dependence Trial in San Francisco (Nicotine, Cannabis, PAX Loose Leaf Vaporizer)

Completed
  • Marijuana Dependence
  • San Francisco, California
    Zuckerberg San Francisco General Hospital
Apr 5, 2021

Cancer Trial in Nijmegen (pazopanib, continental breakfast)

Completed
  • Cancer
  • Nijmegen, Gelderland, Netherlands
    RadboudUMC
Oct 16, 2020

Epilepsy, Intermittent Fasting Trial in Marburg (IF 16:8 as active comparator vs. IF MCT 16:8 as experimental arm)

Recruiting
  • Epilepsy
  • Intermittent Fasting
  • IF 16:8 as active comparator vs. IF MCT 16:8 as experimental arm
  • Marburg, Hessen, Germany
    Philipps University Marburg, Faculty of Medicine, Department of
Aug 24, 2023

Chronic Pain Trial in Winston-Salem (Suture, Dermabond)

Not yet recruiting
  • Chronic Pain
  • Suture
  • Dermabond
  • Winston-Salem, North Carolina
    Wake Forest University Health Sciences
Jun 13, 2023

Hypertension Trial (Aktiia Optical Blood Pressure Monitoring (OBPM) device and antihypertensive drugs)

Not yet recruiting
  • Hypertension
  • Aktiia Optical Blood Pressure Monitoring (OBPM) device and antihypertensive drugs
  • (no location specified)
Mar 21, 2023

Cancer Trial in Pierre-Bénite (The DROP program of pharmaceutical interventions, Standard of care)

Recruiting
  • Cancer
  • The DROP program of pharmaceutical interventions
  • Standard of care
  • Pierre-Bénite, France
    Service pharmaceutique, Unité de Pharmacie Clinique Oncologique,
Oct 28, 2021